240+ leading individuals in healthcare, life sciences and private equity gathered at The Langham Hotel in central London for HPE Europe 2023 for a day packed with fireside chats, in-depth plenary sessions and an abundance of...more
As macroeconomic forces and geopolitical dynamics continue to shape the M&A and investment climate globally, health and life sciences transactions continue to remain high priority sectors presenting both high growth and...more
9/15/2023
/ Acquisitions ,
Austria ,
Capital Markets ,
Denmark ,
France ,
Germany ,
Global Market ,
Health Care Providers ,
Healthcare ,
Healthcare Reform ,
Investment ,
Investors ,
Italy ,
Jurisdiction ,
Life Sciences ,
Mergers ,
Netherlands ,
Poland ,
Regulatory Agenda ,
Spain ,
Switzerland ,
UK ,
United States
McDermott is proudly sponsoring the 2021 Cross-Border M&A and Private Equity Virtual Conference (MUMAC) which will be held virtually, streamed live from the Bayerischer Hof in Munich.
Sessions will include:
- Keynote...more
This year, recognising that as we are still unable to meet in person, our HPE Europe EVENT will be going ahead with two exclusive, virtual extended lunch time sessions.
We will be joined by investors including key players...more
6/9/2021
/ Acquisitions ,
Business Valuations ,
Coronavirus/COVID-19 ,
Financing ,
Health Care Providers ,
Healthcare Facilities ,
Hospitals ,
Investment Opportunities ,
Investors ,
Lenders ,
Leveraged Loans ,
Life Sciences ,
Mergers ,
Physicians ,
Private Equity ,
Private Equity Firms ,
Private Equity Funds ,
Risk Management ,
Webinars
Across the US and EU, life sciences companies are pushing diagnostics, antibody testing, vaccines and other efforts forward to flatten the Coronavirus (COVID-19) curve. Our multidisciplinary cross-border life sciences team...more
5/5/2020
/ Acquisitions ,
Contact Tracing ,
Coronavirus/COVID-19 ,
Cross-Border Transactions ,
Diagnostic Tests ,
Digital Health ,
Divestiture ,
Due Diligence ,
Foreign Investment ,
Health Care Providers ,
Intellectual Property Protection ,
Joint Venture ,
Life Sciences ,
Medical Testing ,
Mergers ,
Partnerships ,
Pharmaceutical Industry ,
Regulatory Oversight ,
Vaccinations ,
Virus Testing ,
Webinars
On October 25, 2016, McDermott Will & Emery held its fifth annual Pharmaceutical/Medtech Dealmaking Symposium in Cambridge, Massachusetts. The day consisted of a series of thought-provoking panels with leading dealmakers in...more
11/21/2016
/ Acquisitions ,
Biotechnology ,
Digital Health ,
EU ,
Innovation ,
Life Sciences ,
Medical Devices ,
Mergers ,
Pharmaceutical Industry ,
UK ,
UK Brexit ,
Venture Capital
In Depth -
UK Withdrawal Process -
The United Kingdom will continue to be an EU member until procedures are completed for exiting the European Union, which is likely to be a long process. Under EU Treaty rules,...more
7/8/2016
/ Alternative Investment Fund Managers Directive (AIFMD) ,
BEPS ,
Counterparties ,
Energy Sector ,
EU ,
EU Passport ,
EU Single Market ,
European Commission ,
European Economic Area (EEA) ,
European Union Trade Mark (EUTM) ,
Financial Institutions ,
Force Majeure Clause ,
Free Trade Agreements ,
Global Marketplace ,
Intellectual Property Protection ,
Member State ,
Mergers ,
MiFID II ,
One-Stop Shop ,
Pharmaceutical Industry ,
Popular ,
Private Equity ,
Referendums ,
Renewable Energy ,
State Aid ,
Takeovers ,
UK ,
UK Brexit ,
UK Competition and Markets Authority (CMA) ,
Unitary Patent ,
Value-Added Tax (VAT) ,
Withholding Tax ,
WTO